KLF6 and prostate carcinoma: In the mouse model of prostate cancer, high expression of KLF6-SV1 can promote tumor cell proliferation and angiogenesis, and likewise reduce apoptosis, thereby mediating tumor invasion, migration, and spread (Ashkenazi and Dixit, 1998; DiFeo et al., 2008).